General Motors, LLC
Summary
NHTSA campaign 22V903: General Motors, LLC recalled for a safety defect. DRLs that do not deactivate as intended may result in a glare, reducing visibility, and increasing the risk of a crash.
Details
Source
nhtsa
External ID
22V903
Action Date
2022-12-08
Status
Ongoing
Category
vehicle
Product Description
General Motors, LLC (GM) is recalling certain 2020-2023 Cadillac CT4 and CT5; 2021-2023 Buick Envision; and 2022-2023 Cadillac Escalade and Escalade ESV, Chevrolet Silverado 1500, Suburban, Tahoe, GMC Sierra 1500, Yukon, and Yukon XL vehicles. The daytime running lights (DRLs) may not deactivate when the headlights are on. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 108, "Lamps, Reflective Devices, and Associated Equipment."
Company
Context & Analysis
General Motors, LLC has 163 FDA actions in our database.
Frequently Asked Questions
How often does General Motors, LLC have FDA actions?
General Motors, LLC has 163 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle